[Cytomegalic retinitis in immunosuppressed patients].
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001766:Blindness / Q000517:prevention & control; D003587:Cytomegalovirus / Q000302:isolation & purification; D003586:Cytomegalovirus Infections; D005260:Female; D006801:Humans; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation; D008297:Male; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000188:drug therapy; D012173:Retinitis / Q000209:etiology* / Q000382:microbiology*
D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents
Zytomegalie-Retinitis bei immunsupprimierten Patienten.